Trans-sinusal maxillary distraction for correction of midfacial hypoplasia: long-term clinical results.
Maxillary distraction osteogenesis is indicated in severe angle class III malocclusions, and severe maxillary hypoplasia among some cleft patients and other craniofacial deformities. Twenty patients, aged 8-48 years (mean 17.8+/-10.5 SD) with maxillary and midfacial hypoplasia were treated. The follow-up period was 13-65 months (mean 35+/-16.3 SD). A trans-sinusal maxillary distractor was placed intraorally at each side of the maxilla. The distraction vector was predicted using specialist software, and was transferred to the patients using stereolithographic models and individual templates. A (high) Le Fort I type osteotomy was performed. The amount of activation varied from 8 to 17.5 mm (mean 13.1+/-2.9 SD). Soft and hard tissue formation resulted in complete healing across the distraction gaps. The distractors are almost completely submerged, and can be left in place as long as necessary to avoid relapse. Wit's appraisal was used to measure the stability of the long-term distraction results. Results up to 5 years after distraction showed considerable maxillary advancement with long-term stability. Ongoing growth of the facial skeleton must be considered when distraction osteogenesis is chosen in growing patients.
Nadjmi
N
N
Department of Cranio-Maxillofacial Surgery, Eeuwfeestkliniek, Harmoniestraat 68, B-2018 Antwerpen, Belgium. drnadjmi@monica.be
Schutyser
F
F
Van Erum
R
R
D000293:Adolescent; D000328:Adult; D002508:Cephalometry; D002648:Child; D002971:Cleft Lip / Q000601:surgery*; D002972:Cleft Palate / Q000601:surgery; D005260:Female; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008297:Male; D008313:Malocclusion, Angle Class III / Q000601:surgery*; D008437:Maxilla / Q000002:abnormalities* / Q000601:surgery; D008443:Maxillary Sinus / Q000002:abnormalities / Q000601:surgery; D008875:Middle Aged; D019857:Osteogenesis, Distraction / Q000295:instrumentation* / Q000379:methods; D019340:Osteotomy, Le Fort / Q000295:instrumentation* / Q000379:methods; D016896:Treatment Outcome